Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ANALYST INTERVIEW: BIOTECHNOLOGY & BETTER COMMUNICATION: DONALD JOHNSTON - AMERICAN HEALTH CONSULTANTS.


(PAJ PAJ Petroleum Association of Japan 901) BIOTECHNOLOGY & BETTER COMMUNICATION: DONALD JOHNSTON Don or Donald Johnston is the name of:
  • Don Johnston (born 1936), Canadian politician and lawyer
  • Donald O. Johnston (born 1929), American composer, music publisher and educator
  • Donald R.
 - AMERICAN HEALTH CONSULTANTS. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 5/8/02. Complete text approximately 3000 words. Document # PAJ901.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:ANALYST INTERVIEW: BIOTECHNOLOGY & BETTER COMMUNICATION: DONALD JOHNSTON - AMERICAN HEALTH CONSULTANTS.(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:93
Previous Article:ANALYST INTERVIEW: INNOVATIVE BIOPHARMACEUTICAL COMPANIES: ED GORDON - PUNK ZIEGEL & CO.
Next Article:ANALYST INTERVIEW: BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC.
Topics:



Related Articles
Feet first for car workers.
CEO INTERVIEW: DONALD SELLERS - SCICLONE PHARMACEUTICALS INC (SCLN).
ANALYST INTERVIEW: OUTLOOK FOR HEALTH CARE SECTORS: GEOFFREY HARRIS - UBS WARBURG.
ANALYST INTERVIEW: BIOTECHNOLOGY INVESTMENT ISSUES: DENNIS PURCELL - PERSEUS-SOROS BIOPHARMACEUTICAL FUND.
ANALYST INTERVIEW: INVESTING IN BIOTECHNOLOGY: MARY GRAY - FEDERATED KAUFMANN FUND.
Names in the News.
Media relations.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles